InvestorsHub Logo
Followers 3418
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: beach_trades post# 57966

Tuesday, 08/14/2012 12:42:26 PM

Tuesday, August 14, 2012 12:42:26 PM

Post# of 97239
HEB..$.475 Hemispherx Biopharma: FDA accepts complete response submission regarding the Ampligen New Drug Application for chronic fatigue syndrome (HEB) 0.44 : Co filed on July 31, 2012 with the FDA its complete response to the FDA's November 25, 2009 Complete Response Letter in support of Ampligen's New Drug Application for Chronic Fatigue Syndrome. On August 10, 2012, the FDA acknowledged in writing receipt of the Company's August 1, 2012, response stating, "We consider this a complete, class 2 response to our November 25, 2009, action letter. Therefore, the user fee goal date (PDUFA) is February 2, 2013."

(On watch here) Question is will this be much higher when the raise occurs or not? ..Sept 18th Annual Mtng where company will use 75m in shares to raise money. http://www.sec.gov/Archives/edgar/data/946644/000114420412044957/v321084_pre14a.htm




Sheff's Station...All Aboard...Sign Up Here!

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.